Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Malignant Solid Neoplasm 1Kidney Neoplasms 1Hematopoietic and Lymphatic System Neoplasm 1HIV Infections 1Endometrial Neoplasms 1Colonic Neoplasms 1Cigarette Smoking-Related Carcinoma 1Carcinoma, Renal Cell 1

Interventions

Etoposide 2liposomal doxorubicin 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1Zidovudine 1Vincristine 1Valganciclovir 1Standard of Care 1Specimen Handling 1Smoking Devices 1Sirolimus 1Rituximab 1Prednisone 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Melphalan 1Magnetic Resonance Spectroscopy 1Interferon-alpha 1Health Promotion 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Educational Status 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Carmustine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Health Promotion × 30 days × Clear all
NCT06708351 2026-05-29

Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial

Emory University

Phase NA Not yet recruiting
2,280 enrolled

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡